The Patient-Centered Outcomes Research (“PCOR”) fee filing deadline is July 31, 2024, for all self-funded medical plansand some HRAs (including individual coverage HRAs (“ICHRAs”)) for […]
The guidance includes
the limits on annual out-of-pocket expenses (deductibles, co-payments, and other amounts, but not premiums) for
non-grandfathered group medical plans for plan years that begin in 2025.
In a recent Fact Sheet FAQ, the Internal Revenue Service (“IRS”) clarified the tax treatment of certain work-life referral(“WLR”) services provided by employers. The FAQ […]
According to a recent FAQ, the Departments of Labor, the Treasury, and Health and Human Services (“HHS”) (collectively, “the Departments”) intend to issue guidance that […]
The Commonwealth of Pennsylvania recently enacted Act 34, Section 202.3 (HB 1300) (“The Act”), which, among other things, amended Pennsylvania law to allow for employer-provided […]
On February 16, 2024, the Alabama Supreme Court (“the Court”), the highest court in the state, ruled that the destruction of
human embryos created through in vitro fertilization (“IVF”) violates the state’s Wrongful Death of a Minor Act (“the Act”). The
Court determined that there is no exception to the Act based on an embryo’s location within or outside of a biological uterus.
On January 22, 2024, the Departments of Labor, Health and Human Services, and the Treasury (collectively, “the
Departments”) answered a new round of FAQs, providing additional guidance on the Affordable Care Act (“ACA”)’s requirement for non-grandfathered medical plans to cover certain preventive services including contraceptives, without cost-sharing.
Employers with employees and/or plan members residing in a state (and/or the District of Columbia) with individual mandate reporting requirements should confirm state reporting requirements with their carrier, TPA or ACA vendor to ensure federal as well as state-level reporting obligations will be met.
Employers sponsoring a group health plan (whether insured or self-insured) need to report information on the creditable (or non-creditable) status of the plan’s prescription drug […]